BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33260191)

  • 1. Immune Checkpoint Inhibitor-Related Pneumonitis.
    Gomatou G; Tzilas V; Kotteas E; Syrigos K; Bouros D
    Respiration; 2020; 99(11):932-942. PubMed ID: 33260191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy-induced pneumonitis in non-small cell lung cancer patients: current concern in treatment with immune-check-point inhibitors.
    Sun Z; Wang S; Du H; Shen H; Zhu J; Li Y
    Invest New Drugs; 2021 Jun; 39(3):891-898. PubMed ID: 33428078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis.
    Wang H; Guo X; Zhou J; Li Y; Duan L; Si X; Zhang L; Liu X; Wang M; Shi J; Zhang L
    Thorac Cancer; 2020 Jan; 11(1):191-197. PubMed ID: 31762218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors.
    Fukihara J; Sakamoto K; Koyama J; Ito T; Iwano S; Morise M; Ogawa M; Kondoh Y; Kimura T; Hashimoto N; Hasegawa Y
    Clin Lung Cancer; 2019 Nov; 20(6):442-450.e4. PubMed ID: 31446020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Findings on Chest CT Performed in the Emergency Department in Patients Receiving Immune Checkpoint Inhibitor Therapy: Single-Institution 8-Year Experience in 136 Patients.
    Smith DA; Radzinsky E; Tirumani SH; Guler E; Petraszko A; Kikano E; Hoimes CJ; Ramaiya NH
    AJR Am J Roentgenol; 2021 Sep; 217(3):613-622. PubMed ID: 33295801
    [No Abstract]   [Full Text] [Related]  

  • 6. Difficulties in differentiating between checkpoint inhibitor pneumonitis and lung metastasis in a patient with melanoma.
    Safa H; Bhosale P; Weissferdt A; Oliva ICG
    Immunotherapy; 2020 Apr; 12(5):293-298. PubMed ID: 32295435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of Oncologic Treatment-Related Pneumonitis: A Focused Review on Emerging Issues of Immune Checkpoint Inhibitor Pneumonitis, From the
    Nishino M
    AJR Am J Roentgenol; 2022 Jan; 218(1):19-27. PubMed ID: 33594904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management.
    Zhang Q; Tang L; Zhou Y; He W; Li W
    Front Immunol; 2021; 12():663986. PubMed ID: 34122422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers.
    Nobashi TW; Nishimoto Y; Kawata Y; Yutani H; Nakamura M; Tsuji Y; Yoshida A; Sugimoto A; Yamamoto T; Alam IS; Noma S
    Br J Radiol; 2020 Nov; 93(1115):20200409. PubMed ID: 32783627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case Report of Checkpoint Inhibitor Pneumonitis Caused by PD-1
Antibody-Safety and Effectiveness of Pirfenidone].
    Yu H; Li J; Yu L; Cheng X; Han X; Zhang X
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):519-525. PubMed ID: 34134189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanoma.
    Baba T; Sakai F; Kato T; Kusumoto M; Kenmotsu H; Sugiura H; Tominaga J; Oikado K; Sata M; Endo M; Yanagawa N; Sasaki S; Iwasawa T; Saito Y; Fujiwara Y; Ohe Y; Yamazaki N; Sakamoto T; Koshiba T; Kuwano K
    Future Oncol; 2019 Jun; 15(16):1911-1920. PubMed ID: 31020849
    [No Abstract]   [Full Text] [Related]  

  • 12. Programmed cell death 1 (PD-1)/PD-ligand 1(PD-L1) inhibitors-related pneumonitis in patients with advanced non-small cell lung cancer.
    Sun Y; Shao C; Li S; Xu Y; Xu K; Zhang Y; Huang H; Wang M; Xu Z
    Asia Pac J Clin Oncol; 2020 Dec; 16(6):299-304. PubMed ID: 32757454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor].
    Wang H; Guo X; Zhou J; Duan L; Si X; Zhang L; Li Y; Liu X; Wang M; Shi J; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Oct; 22(10):621-626. PubMed ID: 31650943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-related adverse events on body CT in patients with small-cell lung cancer treated with immune-checkpoint inhibitors.
    Park H; Hatabu H; Ricciuti B; Aijazi SJ; Awad MM; Nishino M
    Eur J Radiol; 2020 Nov; 132():109275. PubMed ID: 32949913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors.
    Asher N; Marom EM; Ben-Betzalel G; Baruch EN; Steinberg-Silman Y; Schachter J; Shapira-Frommer R; Markel G
    Oncologist; 2019 May; 24(5):640-647. PubMed ID: 30777894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report of nivolumab-related pneumonitis.
    Tada K; Kurihara Y; Myojo T; Kojima F; Ishikawa Y; Yoshiyasu N; Morimoto M; Ito R; Koyamada R; Yamashita T; Bando T; Mori S; Heike Y
    Immunotherapy; 2017 Mar; 9(4):313-318. PubMed ID: 28303763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
    Nishino M; Chambers ES; Chong CR; Ramaiya NH; Gray SW; Marcoux JP; Hatabu H; Jänne PA; Hodi FS; Awad MM
    Cancer Immunol Res; 2016 Apr; 4(4):289-93. PubMed ID: 26865455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Checkpoint Inhibitor Therapy-related Pneumonitis: Patterns and Management.
    Kalisz KR; Ramaiya NH; Laukamp KR; Gupta A
    Radiographics; 2019; 39(7):1923-1937. PubMed ID: 31584861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible primary adrenal insufficiency related to anti-programmed cell-death 1 protein active immunotherapy: Insight into an unforeseen outcome of a rare immune-related adverse event.
    Deligiorgi MV; Trafalis DT
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107050. PubMed ID: 33069924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Tohidinezhad F; Bontempi D; Zhang Z; Dingemans AM; Aerts J; Bootsma G; Vansteenkiste J; Hashemi S; Smit E; Gietema H; Aerts HJ; Dekker A; Hendriks LEL; Traverso A; De Ruysscher D
    Eur J Cancer; 2023 Apr; 183():142-151. PubMed ID: 36857819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.